Related Experiment Videos
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Updated analysis of an outpatient chemoimmunotherapy regimen for treating metastatic melanoma.
The cancer journal from Scientific American·1998
Interleukin-2 therapy after bone marrow or stem cell transplantation for hematologic malignancies.
The cancer journal from Scientific American·1998
Metastatic renal cell carcinoma: long-term survival after therapy with high-dose continuous-infusion interleukin-2.
The cancer journal from Scientific American·1998
Refining risk stratification of patients with early breast cancer eligible for adjuvant abemaciclib or ribociclib.
Journal of the National Cancer Institute·2026
Somatic alterations in TP53, PIK3CA, and CCND1 reveal exposure-driven patterns in oral and oropharyngeal tumors.
Journal of the National Cancer Institute·2026
Inhibitors of IAP/XIAP enhance activity of sacituzumab govitecan.
Journal of the National Cancer Institute·2026
Examining the role of extrachromosomal DNA in lung cancer.
Journal of the National Cancer Institute·2026
Differential impact of lymphocytes on radiation response in autochthonous vs transplant murine sarcomas.
Journal of the National Cancer Institute·2026
Nitrate and nitrite intake and risk of colorectal cancer: a population-based cohort study.
Journal of the National Cancer Institute·2026
ASO Editorial: Lymph Node Dissection in the Immunotherapy Era: Friend or Foe?
Annals of surgical oncology·2026
[Analysis of clinicopathological and immunological characteristics of patients with acquired immune deficiency syndrome-associated diffuse large B-cell lymphoma complicated by Talaromyces marneffei infection].
Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]·2026
Real-World Experience With TRBC1 Immunohistochemistry Across Cutaneous T-Cell Lymphoma Subtypes:A Large Cohort Study.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026
Phase II trial of First-Line Axitinib Plus Nivolumab in Patients with Advanced Mucosal Melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026